NCT04603014View on ClinicalTrials.gov

Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
End Stage Renal Disease on DialysisHemodialysisPeritoneal DialysisNonosmotic Sodium Storage
Interventions
COMBINATION_PRODUCT

Interdialytic peritoneal ultrafiltration with 10% dextrose solution

Interdialytic peritoneal ultrafiltration with incremental doses of a 10% dextrose solution, after hemodialysis twice weekly for three consecutive weeks

Trial Locations (1)

N6A 5W9

London Health Sciences Centre, London

All Listed Sponsors
collaborator

Sequana Medical N.V.

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER